Skip to main content

Concord Medical Services ADR(CCM-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Concord Medical Reports Financial Results for the First Half of 2023

PR Newswire - Fri Sep 22, 2023

BEIJING, Sept. 22, 2023 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2023[1].

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe